Member Log-in

I forgot my password

Not a Member? Register

ProVac Toolkit: Providing Tools to Support Vaccine Decision Making at Country-level

PAHO’s ProVac Initiative helps national immunization programs managers and policymakers make more robust, evidence based decisions. Since 2004, the ProVac Initiative and its collaborators have trained hundreds of people at ministries of health in the Americas and elsewhere on the development and use of vaccine impact, cost and cost-effectiveness data to inform decision making. More than 30 countries have received direct technical assistance to conduct cost or cost-effectiveness analyses on immunization programs from the Initiative.

The ProVac approach involves a clearly defined country-led process for developing evidence to inform decisions on the uptake of new vaccines that increases ownership and trust in the results by national authorities. This toolkit summarizes ProVac tools and guidance developed to date.

You May Also Like

Assessing the Incremental Costs and Savings of Introducing Electronic Immunization Registries and Stock Management Systems: Evidence from the Better Immunization Data Initiative in Tanzania and Zambia

Introduction: poor data quality and use have been identified as key challenges that negatively impact immunization programs in low- and middle-income countries (LMICs). In addition, many LMICs have a shortage of health personnel, and staff available have demanding workloads across several health programs. In order to address these challenges, the Better Immunization Data (BID) Initiative … Continued

Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011–30

ABSTRACT Estimating the value of global investment in immunization programs is critical to helping decision makers plan and mobilize immunization programs and allocate resources required to realize their full benefits. We estimated economic benefits using cost-of-illness and value-of-a-statistical-life approaches and combined this estimation with immunization program costs to derive the return on investment from immunization … Continued

Routine Childhood Immunization During the COVID-19 Pandemic in Africa: A Benefit–risk Analysis of Health Benefits Versus Excess Risk of SARS-CoV-2 Infection

Background National immunization programs globally are at risk of suspension due to the severe health system constraints and physical distancing measures in place to mitigate the ongoing COVID-19 pandemic. We aimed to compare the health benefits of sustaining routine childhood immunization in Africa with the risk of acquiring severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) … Continued

Choose a Language